We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (383)
- Scheduling (national classification system) (164)
- Safety monitoring and information (26)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Medicinal cannabis hub (6)
- Clinical trials (5)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
758 result(s) found, displaying 301 to 325
-
Scheduling decisions (final)Notice of final decision to amend the Poisons Standard in relation to nitrous oxide - Joint ACMS-ACCS#27 (March 2021)
-
Meeting statementsA meeting statement is now available for the last Advisory Committee on Complementary Medicines meeting
-
Meeting statementsAustralian Influenza Vaccine Committee (AIVC) recommendations
-
Corporate reports2020/21 Therapeutic Goods Advertising Compliance Annual Report has been published
-
Corporate reportsSubmissions published and summarised as part of a consultation on clarifying the regulation of 'residual activity' claims for disinfectants.
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Scheduling decisions (final)Notice of the New Chemical Entities that are to be scheduled in the Poisons Standard that comes into effect on 1 October 2021.
-
Meeting statementsA meeting of the Therapeutic Goods Advertising Consultative Committee was held on 23 August 2021.
-
Corporate reportsThis document contains practical information produced by a team from the University of Wollongong, based on their years of practical research on nicotine vaping products.
-
Corporate reportsPractical flowcharts produced by the University of Wollongong based on their years of practical research on nicotine vaping products
-
Corporate reportsOutcomes following review of consultation submissions
-
Corporate reportsThe report cards show the progress made by the TGA in the 3 strategies that make up the Action Plan for Medical Devices.
-
Corporate reportsICMRA brings together the heads of over 40 medicines regulatory authorities, with the WHO as an observer.
-
Corporate reportsThe Australian Government remains committed to the safety, health and wellbeing of all Australians.
-
Scheduling decisions (final)Public notice of final decisions - ACMS#33, ACCS#30, Joint ACMS-ACCS#27 (March 2021).
-
Scheduling decisions (final)Notice on an amendment to the current Poisons Standard in relation to ivermectin
-
Corporate reportsHighlights and Achievements from the International Engagement Strategy 2016-2020
-
-
-
TGA laboratory testing reportsThe TGA has released a report on the laboratory testing of listed medicines for Aconitum alkaloid content.
-
TGA laboratory testing reportsThe TGA has released a report on the laboratory testing of SAS-supplied cannabis products.
-
TGA laboratory testing reportsThe TGA has released a report on the laboratory testing for toxins in medicinal cannabis products.
-
Corporate reportsThese guidelines apply to company-sponsored post-marketing surveillance studies of drug safety and toxicity
-
Meeting statementsA meeting statement from the second meeting of the Dental Sector Working Group is now available.